The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GlaxoSmithKline; Hexal; Janssen-Cilag; Medac; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genomic Health; Janssen-Cilag; Pierre Fabre
Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial.
 
Janning Melanie
Honoraria - Takeda
Consulting or Advisory Role - Sanofi
Research Funding - BerGenBio (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Takeda
 
Volkmar Müller
No Relationships to Disclose
 
Eik Vettorazzi
Research Funding - ResMed (Inst)
 
Miguel Cubas-Cordova
Research Funding - BerGenBio (Inst); Roche/Genentech (Inst)
 
Christine Eulenburg
No Relationships to Disclose
 
Christian Schem
No Relationships to Disclose
 
Peter A. Fasching
Honoraria - Amgen; GlaxoSmithKline; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Novartis; Pfizer; Roche; Teva
Speakers' Bureau - Amgen; GlaxoSmithKline; Novartis; Pfizer; Roche; Teva
Research Funding - Amgen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Thomas Karn
No Relationships to Disclose
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; Novartis; Roche
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; PharmaMar; Roche
Research Funding - Novartis
 
Thorsten Kühn
Consulting or Advisory Role - Genomic Health; Novartis
Speakers' Bureau - Celgene; Genomic Health; Novartis; Roche
Travel, Accommodations, Expenses - Celgene
 
Friedrich Overkamp
No Relationships to Disclose
 
Brigitte Kathrin Rack
Consulting or Advisory Role - Amgen; Novartis
Research Funding - Chugai Pharma (Inst); Janssen Diagnostics (Inst); Lilly (Inst); Novartis (Inst); Sanofi (Inst)
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - AstraZeneca; Celgene; Myriad Genetics; Roche
 
Michael Untch
No Relationships to Disclose
 
Klaus Pantel
No Relationships to Disclose
 
Carsten Bokemeyer
Honoraria - Bayer; Hexal; Lilly/ImClone; Merck KGaA; Roche; Sanofi
Consulting or Advisory Role - Lilly/ImClone; Merck Serono; Sanofi
Travel, Accommodations, Expenses - Merck Serono; Sanofi
 
Sibylle Loibl
No Relationships to Disclose
 
Gunter Von Minckwitz
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)
 
Sonja Loges
Honoraria - Lilly
Consulting or Advisory Role - BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Sanofi
Research Funding - BerGenBio; Roche
Travel, Accommodations, Expenses - BerGenBio; Boehringer Ingelheim; Sanofi